ovarian%20cancer
OVARIAN CANCER
Ovarian cancer is a type of cancer that begins in the ovaries.
It is the 7th most common cancer in women (excluding skin cancer) and the leading cause of death from gynecologic cancer in developed countries.
The 3 histologic types of ovarian cancer are epithelial (primarily seen in women >50 years of age), germ cell (most commonly seen in women <20 years of age) and sex cord stromal (rare and produces steroid hormones).
The median age at the time of diagnosis is 63 years old and >70% present with advanced disease.

    Radiotherapy

    • Eg External beam radiation therapy, brachytherapy
    • Has a limited role in the treatment of ovarian carcinoma
    • May be useful in the palliative phase to reduce complaints due to primary tumor or metastases
      • Used for patients with symptomatic metastases to the bones, supraclavicular or inguinal node, or brain
      • Also helpful in patients with pelvic localizations (eg complaints of nerve plexus compression, bleeding, pain or stasis)
      • Palliative localized radiation therapy is also an option for recurrence treatment
    Digital Edition
    Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
    Sign In To Download
    Editor's Recommendations
    Most Read Articles
    Dr Joslyn Ngu, 16 Mar 2018

    A 2008 clinical practice guideline by the Endocrine Society for hirsutism in premenopausal women has been updated and published in the Journal of Clinical Endocrinology & Metabolism. [https://doi.org/10.1210/jc.2018-00241]

    Pearl Toh, 16 Apr 2018
    Oral micronized progesterone (OMP) may provide relief for perimenopausal women who had hot flashes and night sweats, according to a study presented at the ENDO 2018 Annual Meeting.
    Audrey Abella, 29 Dec 2017
    The use of oral contraceptives reduces the risk of developing rheumatoid arthritis (RA), especially ACPA*-positive RA, according to the Swedish EIRA** study.

    Tristan Manalac, 23 Dec 2017
    Contemporary hormonal contraceptives appear to increase the risk of breast cancer, particularly in those with long durations of exposure, a recent study from Denmark has shown.